Researchers from the Community for Open Antimicrobial Drug Discovery (CO-ADD) have been awarded almost $1 million to develop a new antibiotic that could treat life-threatening bacterial infections resistant to all known antibiotics.
From the DRIVE-AB conference in Brussels to talking Natural Product Chemistry at RACI's symposium in Sydney. It has been a busy September 2017. CO-ADD’s Program Coordinator Dr Mark Blaskovich reports back.
CO-ADD's Dr Karl Hansford has just returned from Boston for the 2017 ASM/ESCMID conference. Read his latest blog post below summarising all the conference activities.
Missed the 'Getting Through the Discovery Wall' antibiotic discovery webinar? Slides and videos from the webinar are now available.
Join CO-ADD on Thursday 2 November for a workshop on the ins and outs of drug discovery and development, part of the National AMR Forum to be held in Brisbane, Australia
